These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18427537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M.
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [Abstract] [Full Text] [Related]

  • 5. [Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
    Ivanets NN, Kinkulkina MA, Tikhonova YG, Iziumina TA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Feb; 115(1):30-34. PubMed ID: 25909786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Trazodone and venlafaxine in treatment of depressive disorders].
    Florkowski A, Gruszczyński W, Gałecki P, Zboralski K, Kołodziejska I, Mikołajczyk I.
    Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML, Garfield LD, Teitelbaum S, Civitelli R, Mulsant BH, Reynolds CF, Dixon D, Doré P, Lenze EJ.
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA, Mourad L, ter Haar J, Egberts AC.
    Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1370-2. PubMed ID: 12892015
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.
    J Psychopharmacol; 2010 Aug 12; 24(8):1209-16. PubMed ID: 19939870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Venlafaxine: not yet first in the antidepressant class.
    Harv Ment Health Lett; 2003 Apr 12; 19(10):5-7. PubMed ID: 12711568
    [No Abstract] [Full Text] [Related]

  • 18. Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?
    Luisi S, Castrogiovanni A, Ciani V, Pacchierotti C, Capua AD, Pasquini R, Lazzeri L, Petraglia F.
    Gynecol Endocrinol; 2012 Jan 12; 28(1):68-71. PubMed ID: 22087587
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
    Rickels K, Pollack MH, Sheehan DV, Haskins JT.
    Am J Psychiatry; 2000 Jun 12; 157(6):968-74. PubMed ID: 10831478
    [Abstract] [Full Text] [Related]

  • 20. Dose-related paresthesias with venlafaxine.
    Angelo LJ, Lee KC.
    J Pharm Pract; 2013 Oct 12; 26(5):514-7. PubMed ID: 23764565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.